Skip to content

Clinical trials

Observational Language Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Language Disorders Phase: Observational Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20111
20121
20191
20212
20222
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting2
Recruiting2
Terminated2
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Douglas Mental Health University Institute2
National Institute of Neurological Disorders and Stroke (NINDS)2
Centre Hospitalier Universitaire, Amiens1
Children's Hospital of Fudan University1
Fondazione Don Carlo Gnocchi ETS1
IRCCS San Camillo, Venezia, Italy1
IRCCS San Raffaele1
Lille Catholic University1
National Institute on Deafness and Other Communication Disorders (NIDCD)1
Pontificia Universidad Catolica de Chile1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Language Disorders16
Language Development Disorders3
Aphasia2
Autism Spectrum Disorder2
Autistic Disorder2
Intellectual Disability2
Psychotic Disorders2
Schizophrenia2
Anxiety Disorders1
Auditory Perceptual Disorders1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.